-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
in Pharmacology |
|
Submit your manuscript
Scope
The section publishes articles on all aspects of pre-clinical and clinical pharmacology of drugs for the treatment of respiratory diseases. Within the scope of Respiratory Pharmacology are also publications covering aspects that are relevant for a personalized and more rational pharmacological therapy of respiratory diseases, including the development of new non-invasive techniques for assessing and monitoring lung inflammation and pharmacological response, elucidation of pharmacokinetic/pharmacodynamic characteristics of approved drugs, identification of best treatment outcomes, and the role of phenotyping in drug response variability. Particular attention will be paid to new drugs and new pharmacological strategies for treatment of respiratory diseases and multidisciplinary translational research for the pharmacotherapy of respiratory diseases.Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
Respiratory Pharmacology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology and Code.
All manuscripts must be submitted directly to the section Respiratory Pharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Respiratory Pharmacology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact pharmacology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact pharmacology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org